Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Medical Journal of Australia|January 21, 2014
Do outlier inpatients experience more emergency calls in hospital? An observational cohort studyJohn D Santamaria, Antony E Tobin, Matthew H Anstey, et al.Internal Medicine Journal|April 20, 2017
Use of resuscitation plans at a tertiary Australian hospital: room for improvementRoger J Smith, John D Santamaria, Jennifer A Holmes, et al.Journal of Critical Care|May 19, 2015
The duration of hospitalization before review by the rapid response team: A retrospective cohort studyRoger J Smith, John D Santamaria, Espedito E Faraone, et al.Anaesthesia and Intensive Care|March 27, 2025
A randomised, open-label trial of nebulised unfractionated heparin in patients mechanically ventilated for COVID-19Roger J Smith, Angajendra N Ghosh, Simone Said, et al.Drug and Chemical Toxicology|October 14, 2008
Temporal evaluation of CYP mRNA in mice administered with prototypical P450 inducers: comparison with conventional protein/enzyme methodsEr-Jia Wang, George Mandakas, Jairam Palamanda, et al.Toxicology and Applied Pharmacology|September 29, 2004
Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicityJohn W Davis, Federico M Goodsaid, Christopher M Bral, et al.The Lancet. Respiratory Medicine|January 25, 2021
Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trialBarry Dixon, Roger J Smith, Duncan J Campbell, et al.Intensive Care Medicine Experimental|February 7, 2025
Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label studyDavid Cosgrave, Bairbre McNicholas, Ciara Hanley, et al.Pageof 2